Clinical Trial - Trial ChiCTR2200058059
Access comprehensive clinical trial information for ChiCTR2200058059 through Pure Global AI's free database. This Phase 1 trial is sponsored by Peking University People's Hospital and is currently Recruiting. The study focuses on Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200058059
Phase 1
Recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200058059
View on Chinese Clinical Trial Registry
Untitled Trial
A prospective clinical study of Azacitidine combined with or without Venetoclax for the maintenance treatment of post-remission acute myeloid leukemia
Study Focus
Sponsor & Location
Peking University People's Hospital
National Natural Science Foundation of China
China
Timeline & Enrollment
Phase 1
N/A
Dec 31, 2022
ICD-10 Classifications
Leukaemia, unspecified
Myeloid leukaemia
Myeloid leukaemia, unspecified
Other myeloid leukaemia
Monocytic leukaemia, unspecified
Data Source
Chinese Clinical Trial Registry
ChiCTR2200058059
Non-Device Trial